WEDNESDAY, Sept. 11, 2024 (HealthDay News) -- An experimental blood test could one day help identify people most likely to ...

MONDAY, Sept. 16, 2024 (HealthDay News) -- Tiny puffs from asthma inhalers could be causing big climate problems for Mother Earth, a new study warns. Each inhaler dose contains some of the most potent ...

People in the United States die the earliest and live the sickest lives out of 10 developed countries, even though the United ...

GOLD COPD Report includes updated research and recommendations that reflect shifts in thinking on COPD management.

The global pulmonary function testing devices market revenue was around US$ 2.0 billion in 2022 and is estimated to reach US$ 3.5 billion by 2031, growing at a compound annual growth rate (CAGR) of ...

U.S. News & World Report has solidified a timeline and methodology for its annual rankings for children's hospitals. On Sept. 17, hospitals that submitted data to U.S. News in 2024 will receive access ...

The "Chronic Obstructive Pulmonary Disease (COPD): Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. In the 7MM, the total prevalent cases of COPD are expected ...

A UPMC pulmonologist talks about the symptoms, explains who is most at risk for a severe infection, and tells us how ...

TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the ...

AstraZeneca’s FASENRA ® (benralizumab) has been approved in the US for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). 1 EGPA is a rare, immune-mediated ...